Skip to content

Emergency Stroke Unit for Minor Ischemic Stroke——A prospective, single-center, week-wise randomized, controlled trial

Emergency Stroke Unit for Minor Ischemic Stroke——A prospective, single-center, week-wise randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115813
Enrollment
Unknown
Registered
2025-12-31
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild stroke

Interventions

ESU group:Intravenous thrombolysis and/or mechanical thrombectomy
Traditional stroke unit group:Intravenous thrombolysis and/or mechanical thrombectomy

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. The time from onset to treatment/hospitalization is <= 6 hours; 1.the time when symptoms begin is defined as the time when they last show normal symptoms; 3. Clinical diagnosis of ischemic stroke; 2.four MRS score 0-1 before onset; 3.five Baseline NIHSS <= 5 points; 4.six The subject or guardian voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. NIHSS score>5 points; 2. Fear of confinement prevents completion of magnetic resonance imaging examination Check; 3. Cardiac pacemaker/brain pacemaker/insulin pump safety Pretending to be a patient; 4. Intravenous thrombolysis (rt PA)/endovascular thrombectomy treatment Treatment taboos; 5.A: Absolute contraindication for intravenous thrombolysis (rt PA) therapy 1- three B: Does not meet the treatment criteria for endovascular thrombectomy 1,4 5. Post seizure hemiplegia (Todd's paralysis) Or combined with other neurological/psychiatric disorders and unable to cooperate Or subjects who are unwilling to cooperate; 6. Pregnant women, lactating women, or different Intended to adopt effective contraceptive measures during the trial period Testers; 7. Participated in other clinical trials within the past 3 months; 8. Judged by the investigator to be unsuitable for this study or participation in this study may pose greater risks to the subject

Design outcomes

Primary

MeasureTime frame
Utility-weighted mRS score.;

Secondary

MeasureTime frame
NIHSS score;

Countries

China

Contacts

Public ContactWenli Xing

Suining Central Hospital

383324137@qq.com+86 825 226 7526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026